In this study, levels of lipid peroxidation and antioxidant enzyme activities were investigated in the erythrocytes of patients with oesophageal and gastric cancers. Erythrocytes were obtained from 17 patients with oesophageal cancer, 37 patients with gastric cancer and 20 healthy controls. Levels of malondialdehyde (MDA), a lipid peroxidation marker, and activities of copper- and zinc-containing superoxide dismutase (CuZn-SOD), catalase (CAT) and glutathione peroxidase (GPx) were determined using spectrophotometric methods. MDA levels and CuZn-SOD activity were significantly higher and GPx and CAT activities significantly lower in patients with oesophageal and gastric cancer than in controls. There were no statistically significant differences in the parameters measured in relation to disease stage in either patient group. These results indicate significant changes in the antioxidant defence system in patients with oesophageal and gastric cancer. It is postulated that this may lead to enhanced action of oxygen radicals, resulting in lipid peroxidation.
DaviesKJ: Oxidative stress: The paradox of aerobic life. Biochem Soc Symp1995; 61: 1–31.
2.
HalliwellB: Antioxidants and human disease: A general introduction. Nutr Rev1997; 55: S44–S52.
3.
HalliwellBGutteridgeJ: Protection against oxidants in biological systems: The superoxide theory of oxygen toxicity. In: Free Radicals in Biology and Medicine, (HalliwellBGutteridgeJ, eds). Oxford: Clarendon Press, 1989; pp86–179.
4.
MantovaniGMaccioAMadedduCMuraLGramignanoGLussoMR: Quantitative evaluation of oxidative stress, chronic inflammatory indices and leptin in cancer patients: Correlation with stage and performance status. Int J Cancer2002; 98: 84–91.
5.
YangJLamEWHammadHMOberleyTDOberleyLW: Antioxidant enzyme levels in oral squamous cell carcinoma and normal human oral epithelium. J Oral Pathol Med2002; 31: 71–77.
6.
GulMKutayFZTemocinSHanninenO: Cellular and clinical implications of glutathione. Indian J Exp Biol2000; 38: 625–634.
7.
MichielsCRaesMToussaintORemacleJ: Importance of Se-glutathione peroxidase, catalase, and Cu/Zn-SOD for cell survival against oxidative stress. Free Radic Biol Med1994; 17: 235–248.
8.
PolatMFTaysiSGulMCikmanOYilmazIBakanE: Oxidant/antioxidant status in blood of patients with malignant breast tumour and benign breast disease. Cell Biochem Funct2002; 20: 327–331.
9.
OberleyTD: Oxidative damage and cancer. Am J Pathol2002; 160: 403–408.
10.
TaysiSPolatFGulMSariRABakanE: Lipid peroxidation, some extracellular antioxidants, and antioxidant enzymes in serum of patients with rheumatoid arthritis. Rheumatol Int2002; 21: 200–204.
11.
TaysiSGulMSariRAAkcayFBakanN: Serum oxidant/antioxidant status of patients with systemic lupus erythematosus. Clin Chem Lab Med2002; 40: 684–688.
12.
SamirMel KholyNM: Thiobarbituric acid reactive substances in patients with laryngeal cancer. Clin Otolaryngol Allied Sci1999; 24: 232–234.
13.
BakanETaysiSPolatMFDalgaSUmudumZBakanN: Nitric oxide levels and lipid peroxidation in plasma of patients with gastric cancer. Jpn J Clin Oncol2002; 32: 162–166.
14.
TaysiSUsluCAkcayFSutbeyazMY: Malondialdehyde and nitric oxide levels in the plasma of patients with advanced laryngeal cancer. Surg Today2003; 33: 651–654.
15.
StoneWLPapasAM: Tocopherols and the etiology of colon cancer. J Natl Cancer Inst1997; 89: 1006–1014.
16.
SobinLHWittekindCH, (eds): TNM Classification of Malignant Tumours, 5th edn.International Union Against Cancer. New York: Wiley-Liss, 1997; pp59–62.
17.
JainSKMcVieRDuettJHerbstJJ: Erythrocyte membrane lipid peroxidation and glycosylated hemoglobin in diabetes. Diabetes1989; 38: 1539–1543.
18.
SunYOberleyLWLiY: A simple method for clinical assay of superoxide dismutase. Clin Chem1988; 34: 497–500.
19.
PagliaDEValentineWN: Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med1967; 70: 158–169.
JarugaPZastawnyTHSkokowskiJDizdarogluMOlinskiR: Oxidative DNA base damage and antioxidant enzyme activities in human lung cancer. FEBS Lett1994; 341: 59–64.
BlackburnRVSpitzDRLiuXGaloforoSSSimJERidnourLA: Metabolic oxidative stress activates signal transduction and gene expression during glucose deprivation in human tumor cells. Free Radic Biol Med1999; 26: 419–430.
24.
ToyokuniSOkamotoKYodoiJHiaiH: Persistent oxidative stress in cancer. FEBS Lett1995; 358: 1–3.
25.
MeyerTELiangHQBuckleyARBuckleyDJGoutPWGreenEH: Changes in glutathione redox cycling and oxidative stress response in the malignant progression of NB2 lymphoma cells. Int J Cancer1998; 77: 55–63.
26.
NavarroJObradorECarreteroJPetschenIAvinoJPerezP: Changes in glutathione status and the antioxidant system in blood and in cancer cells associate with tumour growth in vivo. Free Radic Biol Med1999; 26: 410–418.
27.
SevenACivelekSInciEInciFKorkutNBurcakG: Evaluation of oxidative stress parameters in blood of patients with laryngeal carcinoma. Clin Biochem1999; 32: 369–373.
28.
MarnettLJ: Lipid peroxidation - DNA damage by malondialdehyde. Mutat Res1999; 424: 83–95.
29.
HuangYLSheuJYLinTH: Association between oxidative stress and changes of trace elements in patients with breast cancer. Clin Biochem1999; 32: 131–136.
30.
ArivazhaganSKavithaKNaginiS: Erythrocyte lipid peroxidation and antioxidants in gastric cancer patients. Cell Biochem Funct1997; 15: 15–18.
31.
AlagolHErdemESancakBTurkmenGCamlibelMBugdayciG: Nitric oxide biosynthesis and malondialdehyde levels in advanced breast cancer. Aust N Z J Surg1999; 69: 647–650.
32.
GerberMAstreCSegalaCSaintotMScaliJSimony-LafontaineJ: Oxidant-antioxidant status alterations in cancer patients: Relationship to tumor progression. J Nutr1996; 126 (4 suppl): 1201S–1207S.
33.
SevenAErbilYSevenRInciFGulyasarTBarutcuB: Breast cancer and benign breast disease patients evaluated in relation to oxidative stress. Cancer Biochem Biophys1998; 16: 333–345.
34.
PortakalOOzkayaOInalM ErdenBozanBKosanMSayekI: Coenzyme Q10 concentrations and antioxidant status in tissues of breast cancer patients. Clin Biochem2000; 33: 279–284.
35.
GerberMAstreCSegalaCSaintotMScaliJSimony-LafontaineJ: Tumor progression and oxidant-antioxidant status. Cancer Lett1997; 114: 211–214.
36.
GuvenMOzturkBSayalAOzeturkAUlutinT: Lipid peroxidation and antioxidant system in the blood of cancerous patients with metastasis. Cancer Biochem Biophys1999; 17: 155–162.
37.
SkrzydlewskaEStankiewiczASulkowskaMSulkowskiSKasackaI: Antioxidant status and lipid peroxidation in colorectal cancer. J Toxicol Environ Health A2001; 64: 213–222.
38.
FridovichI: Superoxide radical and superoxide dismutases. Annu Rev Biochem1995; 64: 97–112.
39.
BabiorBM: Phagocytes and oxidative stress. Am J Med2000; 109: 33–44.
